Rep. Haggerty applauds passage of Bill to Combat Substance Use Disorder
BOSTON – State Representative Richard M. Haggerty (D-Woburn) was pleased to join his colleagues in the Legislature to pass H.5143, “An Act relative to treatments and coverage for substance use disorder and recovery coach licensure,” that will expand non-opioid pain treatments, establish licenses for recovery coaches, and support pregnant people and their children who have been exposed to substances.
“The opioid crisis has touched the lives of far too many families, and its devastating impact continues to be felt in communities across our state,” said Representative Haggerty. “This bill, through its multifaceted approach, makes life-saving treatments more available and makes it easier for those struggling to get the help they need.”
The bill will vastly expand access to opioid-reversal drugs like naloxone. In 2023, 2,125 lives were lost as a result of an overdose, 232 fewer than in 2022, according to the Department of Public Health (DPH). Since 2023, naloxone has reversed more than 10,000 overdoses in Massachusetts.
The legislation mandates that all health plans cover opioid reversal drugs such as naloxone and Narcan—without cost-sharing or prior authorization. It also requires hospitals and substance use treatment facilities to educate patients on opioid reversal drugs and prescribe or dispense at least two doses to at-risk patients upon discharge. It also requires pharmacies in areas with high incidences of overdoses to maintain a sufficient and consistent supply of opioid reversal drugs while requiring them to stock both over the counter and prescription versions.
The bill includes several new insurance provisions, including a prohibition on life insurance companies from limiting or refusing coverage to a person solely because they obtained an opioid-reversal drug, and a prohibition on medical malpractice insurers from discriminating against health care practitioners who provide harm reduction services. It further updates requirements for insurance providers to ensure adequate coverage and access to pain management services including non-opioid treatments and expands access to non-opioid pain treatment by incorporating non-opioid alternatives into provider training.
No person should face discrimination because of substance use disorder or receiving medication for it in the past. This legislation therefore clarifies DPH’s authority to enforce anti-discrimination protections for people with SUD who are covered by public health insurance and prohibits discrimination against those lawfully possessing or taking medication for opioid-related SUD treatment.
Further, the bill protects public health and harm reduction organizations and their agents from professional disciplinary action or civil or criminal liability if they are providing drug checking services in good faith. It also protects individuals from criminal liability when seeking treatment from such organizations. This change should help detect and protect against deadly contaminants that are increasingly found in the drug supply.
Having passed both chambers of the Legislature, the measure will now be sent to the Governor’s desk for her signature.
###

